NYSE:OGN

PT. Organon Pharma Indonesia Tbk.

Stock

USD

Last Close

6.71

06/11 22:31

Market Cap

5.12B

Beta: -

Volume Today

29.84M

Avg: 2.10M

PE Ratio

7.03

PFCF: 9.70

Dividend Yield

6.96%

Payout:50.26%

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24
revenue	9.78B -	7.78B 20.46%	8.10B 4.10%	6.30B 22.13%	6.17B 2.06%	6.26B 1.44%	6.40B 2.24%
cost of revenue	4.69B -	2.27B 51.54%	3.35B 47.19%	2.38B 28.83%	2.29B 3.69%	2.52B 9.63%	2.69B 6.88%
gross profit	5.08B -	5.50B 8.24%	4.75B 13.70%	3.92B 17.41%	3.88B 1.07%	3.75B 3.40%	3.71B 0.88%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses	2.01B -	1.44B 28.32%	1.67B 15.45%	1.67B 0.12%	1.70B 2.16%	1.89B 11.09%	1.76B 7.03%
research and development expenses	365M -	220M 39.73%	304M 38.18%	443M 45.72%	471M 6.32%	536M 13.80%	469M 12.50%
other expenses	142M -	7M 95.07%	-29M 514.29%	-279M 862.07%	-15M 94.62%	-15M 0%
cost and expenses	7.07B -	3.94B 44.32%	5.32B 35.05%	4.49B 15.50%	4.47B 0.53%	4.94B 10.63%	4.92B 0.55%
operating expenses	2.38B -	1.66B 30.07%	1.97B 18.46%	2.11B 7.16%	2.17B 3.03%	2.43B 11.68%	2.23B 8.23%
interest expense				258M -	422M 63.57%	527M 24.88%	520M 1.33%
ebitda	4.50B -	4.18B 7.07%	3.01B 28.09%	1.81B 39.65%	1.69B 6.84%	1.55B 8.11%	1.61B 3.86%
operating income	2.71B -	3.85B 42.17%	2.85B 25.94%	1.62B 43.17%	1.48B 8.71%	1.32B 10.76%	1.49B 12.66%
depreciation and amortization	1.67B -	333M 80.10%	157M 52.85%	195M 24.20%	212M 8.72%	234M 10.38%	277M 18.38%
total other income expenses net	23M -	-151M 756.52%	-169M 11.92%	-90M 46.75%	-356M 295.56%	-646M 81.46%	-679M 5.11%
income before tax	2.73B -	3.70B 35.43%	2.68B 27.49%	1.53B 42.95%	1.12B 26.62%	673M 40.02%	807M 19.91%
income tax expense	576M -	390M 32.29%	520M 33.33%	178M 65.77%	205M 15.17%	-350M 270.73%	-57M 83.71%
net income	2.15B -	3.22B 49.47%	2.16B 32.88%	1.35B 37.45%	917M 32.12%	1.02B 11.56%	864M 15.54%
weighted average shs out	253.13M -	253.13M 0%	253.13M 0%	253.54M 0.16%	254.08M 0.21%	255.24M 0.46%	257.05M 0.71%
weighted average shs out dil	253.13M -	253.13M 0%	253.13M 0%	254.19M 0.42%	255.17M 0.38%	256.27M 0.43%	259.15M 1.12%
eps	8.51 -	12.71 49.35%	8.53 32.89%	5.33 37.51%	3.61 32.27%	4.01 11.08%	3.36 16.21%
epsdiluted	8.51 -	12.71 49.35%	8.53 32.89%	5.31 37.75%	3.59 32.39%	3.99 11.14%	3.33 16.54%

All numbers in USD (except ratios and percentages)